CN101139579B - Method for preparing cross-linking bacillus subtilis proteinase crystal - Google Patents

Method for preparing cross-linking bacillus subtilis proteinase crystal Download PDF

Info

Publication number
CN101139579B
CN101139579B CN2007100257824A CN200710025782A CN101139579B CN 101139579 B CN101139579 B CN 101139579B CN 2007100257824 A CN2007100257824 A CN 2007100257824A CN 200710025782 A CN200710025782 A CN 200710025782A CN 101139579 B CN101139579 B CN 101139579B
Authority
CN
China
Prior art keywords
crystal
bacillus subtilis
solution
linking
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007100257824A
Other languages
Chinese (zh)
Other versions
CN101139579A (en
Inventor
姚亦明
袁方
李锐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Ronnsi Biotechnology Co., Ltd.
Original Assignee
ZHANGJIAGANG AOJIE BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHANGJIAGANG AOJIE BIOLOGICAL TECHNOLOGY Co Ltd filed Critical ZHANGJIAGANG AOJIE BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN2007100257824A priority Critical patent/CN101139579B/en
Publication of CN101139579A publication Critical patent/CN101139579A/en
Application granted granted Critical
Publication of CN101139579B publication Critical patent/CN101139579B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a preparing method for a cross-linked subtilisin crystal that is of simple process and steady performance, which comprises the following procedures: (I) mixing subtilisin solution 2-10% (mass concentration) and salt solution 10-30% (mass concentration) in proportion 1:1 swung dash 1:5, agitating till crystal separates from the solution; (II) filtering the separated crystaland scrubbing by salt solution at least 4 times; (III) adding the crystal into salt solution to get suspension fluid of subtilisin crystal; (IV) adding slowly double-functional cross-linking agent into the suspension fluid of subtilisin crystal and agitating 3-16 hours, the added amount is 1-5 times by weight of subtilisin crystal; (V) filtering or centrifuging the reaction solution to get coarsecross-linked subtilisin crystal, scrubbing 2-8 times by de-ionized water the coarse crystal, then scrubbing by a buffering liquid, till getting the desired cross-linked subtilisin crystal.

Description

A kind of preparation method of cross-linking bacillus subtilis proteinase crystal
Technical field
The present invention relates to a kind of preparation method of cross-linking bacillus subtilis proteinase crystal.
Background technology
Enzyme (Enzyme) is the protein with height specificity and catalytic efficiency that produces in the viable cell, is called biological catalyst again.Organism is in metabolic processes, and nearly all chemical reaction all is to carry out under the catalysis of enzyme.Human of long standing and well established to the understanding of enzyme.The summer Yu epoch of China before more than 4,000 year, just wine brewing was in vogue, had begun the Zhou Dynasty to make vinegar, sauce, and had treated maldigestion with song.The systematic study of enzyme originates in the middle of the 19th century to the essential research of fermenting.1858, French chemistry and biologist Louis pasteur (Louis Pasteur) were the phenomenons relevant with life with the fermentation of a series of article proof.But 1897, German famous chemist Edward Bi Xina (Eduard Buchner) successfully realized fermentation with not celliferous yeast juice, illustrates that the material with fermentative action is present in the cell, does not rely on viable cell.This material is exactly an enzyme.Nineteen twenty-six American Sumner (James Batcheller Sumner) extracts urase first, and carries out crystallization, and points out that the essence of enzyme is protein.
These scientific researches have effectively promoted human understanding and use to enzyme.Now, existing two over thousands of kinds of enzymes are identified out, wherein have 200 surplus kind obtain crystallization.Particularly in the last thirty years, along with the progress of protein stripping technique, the molecular structure of enzyme, the research of enzyme mechanism are developed, and the structure of some enzyme and the mechanism of action are illustrated.
As biological catalyst (biological catalyst), enzyme has the characteristic of two aspects.Its existing and general identical catalytic property of catalyzer has the feature of the unexistent biomacromolecule of general catalyzer again.For example, enzyme is the same with general catalyzer, and the chemical reaction that can only catalysis thermodynamics allows shortens and reaches the time of chemical equilibrium, and does not change trim point.In addition, enzyme does not have the change of quality and quantity as catalyzer in the front and back of chemical reaction, and the enzyme of trace just can be brought into play bigger katalysis.The mechanism of action of enzyme and general catalyzer all is to reduce the activation energy (activation energy) of reaction.
Simultaneously, enzyme has the catalytic efficiency of height, the specificity of height, the controllability of enzymic activity, the characteristics such as unstable of enzymic activity again as the protein catalyzed reaction.Wherein, the preceding several characteristics of enzyme allows people see the bright prospect that zymochemistry is used, and still, the unstable of enzyme has but seriously restricted further developing of enzyme.As protein, enzymic catalytic reaction requires gentle condition such as certain pH value, temperature, and any chemical factors of protein denaturation that makes such as strong acid, highly basic, organic solvent, heavy metallic salt, high temperature, ultraviolet ray, concuss all may make enzyme denaturation and lose its catalytic activity.
Subtilisin is a kind of very important industrial enzymes.Widespread use washing composition, makeup and asymmetry catalysis are synthetic.But subtilisin is very unstable.Understand self hydrolysis and inactivation.The crosslinked enzyme crystal technology is a kind of very effective enzyme stabilization technology.But still do not find the preparation method of relevant cross-linking bacillus subtilis proteinase at present.
Summary of the invention
Technical problem to be solved by this invention is: will provide that a kind of technology is simple, the preparation method of the cross-linking bacillus subtilis proteinase crystal of stable performance.
For addressing the above problem, the technical solution used in the present invention is: the preparation method of described cross-linking bacillus subtilis proteinase crystal may further comprise the steps:
(1) under 4~65 ℃, with mass concentration is that 2%~10% subtilisin solution and mass concentration are 10%~30% 1: 1 by volume~1: 5 mixed of metabisulfite solution, under the stirring velocity of 50~1000rpm/min, stirred 6~7 days, and had bacillus subtilis proteinase crystal to separate out in the solution;
(2) under 4~30 ℃, the crystal of separating out is filtered, again through metabisulfite solution washing at least 4 times;
(3) washed crystal is added in the metabisulfite solution, stirred 1~3 hour, get the bacillus subtilis proteinase crystal suspension liquid;
(4) at 4~45 ℃, under the stirring velocity of 300~1000rpm/min, with bi-functional cross-linking agent-mass concentration is that 25% glutaraldehyde slowly adds in the bacillus subtilis proteinase crystal suspension liquid, and add-on is 1~5 times of bacillus subtilis proteinase crystal weight, stirs 5 hours;
(5) after filtration or centrifugal cross-linking bacillus subtilis proteinase crystal crude product with reaction solution, the cross-linking bacillus subtilis proteinase crystal crude product that obtains is used deionized water wash 2~8 times earlier, with the damping fluid washing, stop washing less than 0.5 again up to the ultraviolet absorption value of scrub stream fluid under 280nm; Obtain required cross-linking bacillus subtilis proteinase crystal.
In actual fabrication, for ease of preserving, the ratio of cross-linking bacillus subtilis proteinase crystal according to weight ratio 5%~30% can be added in the damping fluid, stirred 1~2 hour, obtain the suspension liquid of cross-linking bacillus subtilis proteinase crystal.
Temperature in the above-mentioned steps () is preferably 44~55 ℃, and stirring velocity is preferably 280~320rpm/min.
Metabisulfite solution concentration preferred 15%~20% described in above-mentioned steps (), (two) and (three).
Preferred 28~35 ℃ of temperature of reaction described in the above-mentioned steps (four), described stirring velocity is 480~520rpm/min.In this step, enzyme crystal Weight Calculation method can detect by ultraviolet spectrophotometry and obtain, promptly get the resulting enzyme crystal suspension liquid of 1 milliliter of step (three), 300 times of dilute with waters, under 280nm, measure its uv-absorbing, be calculated as follows the weight of enzyme crystal: enzyme crystal concentration=UV 280 ultraviolet absorption values * 1.009 * 300g/L; Enzyme crystal weight=enzyme crystal concentration * enzyme crystal suspension liquid volume.
Above-mentioned damping fluid is for containing 100mM NaAc and 20mM CaCl 2The aqueous solution, the pH value of solution value is 5.5~5.85.
The invention has the beneficial effects as follows: described method cost is low, technology is simple and environmental protection, be easy to realize that the cross-linked ester crystal that makes has high stability, high purity, high reactivity, but the building-up reactions of catalysis chipal compounds.
Embodiment
The invention will be further described below by specific embodiment, but the present invention is not limited in these embodiment.
Embodiment 1:
At 35 ℃, 100ml subtilisin solution (mass concentration is about 5%) and 200ml, 15% metabisulfite solution are pressed the volume ratio of 1:2 and mixed, under the magnetic agitation of 100rpm/min, there is crystal to separate out after 6 days; Under 22 ℃, the gained crystal is filtered, wash 6 times with 15% metabisulfite solution again; The gained crystal is added in 100ml, the 15% sodium sulfate buffered soln once more, stirred 2 hours, obtain bacillus subtilis proteinase crystal suspension solution (cumulative volume is 100 milliliters).
At 35 ℃, 400rpm/min stirs down, is that 25% glutaraldehyde (be enzyme crystal weight 3.36 times) slowly adds in the bacillus subtilis proteinase crystal suspension solution with mass concentration, stirs 5 hours; With reaction solution after filtration subtilisin crosslinked enzyme crystal crude product, earlier with deionized water wash 5 times, again with pH5.7 and contain 100mM NaAc and 20mM CaCl 2Damping fluid washing, stop washing up to the ultraviolet absorption value of scrub stream fluid under 280nm less than 0.5; The cross-linking bacillus subtilis proteinase crystal that obtains added again contain 100mM NaAc and 20mM CaCl 2Damping fluid in, stirred 1 hour, promptly get the cross-linking bacillus subtilis proteinase crystal suspension liquid.
Embodiment 2:
With embodiment 1 described preparation method, different is at 50 ℃, it is that 20% metabisulfite solution mixes by the volume ratio of 1:2 that mass concentration is about 5% subtilisin solution and concentration, under the magnetic agitation of 100rpm/min, has crystal to separate out after 6 days.All the other steps are identical.
Embodiment 3:
With embodiment 1 described preparation method, different is at 10 ℃, and the metabisulfite solution that mass concentration is about 5% subtilisin solution and 10% mixes by the volume ratio of 1:2, under the magnetic agitation of 100rpm/min, has crystal to separate out after 6 days.All the other steps are identical.

Claims (6)

1. the preparation method of a cross-linking bacillus subtilis proteinase crystal is characterized in that: may further comprise the steps:
(1) under 4~65 ℃, with mass concentration is that 2%~10% subtilisin solution and mass concentration are 10%~30% 1: 1 by volume~1: 5 mixed of metabisulfite solution, under the stirring velocity of 50~1000rpm/min, stirred 6~7 days, and had bacillus subtilis proteinase crystal to separate out in the solution;
(2) under 4~30 ℃, the crystal of separating out is filtered, again through metabisulfite solution washing at least 4 times;
(3) washed crystal is added in the metabisulfite solution, stirred 1~3 hour, get the bacillus subtilis proteinase crystal suspension liquid;
(4) at 4~45 ℃, under the stirring velocity of 300~1000rpm/min, with bi-functional cross-linking agent--mass concentration is that 25% glutaraldehyde slowly adds in the bacillus subtilis proteinase crystal suspension liquid, and add-on is 1~5 times of bacillus subtilis proteinase crystal weight, stirs 5 hours;
(5) after filtration or centrifugal cross-linking bacillus subtilis proteinase crystal crude product with reaction solution, the cross-linking bacillus subtilis proteinase crystal crude product that obtains is used deionized water wash 2~8 times earlier, with the damping fluid washing, stop washing less than 0.5 again up to the ultraviolet absorption value of scrub stream fluid under 280nm; Obtain required cross-linking bacillus subtilis proteinase crystal.
2. preparation method according to claim 1, it is characterized in that: for ease of preserving, the ratio of cross-linking bacillus subtilis proteinase crystal according to weight ratio 5%~30% added in the damping fluid, stirred 1~2 hour, obtain the suspension liquid of cross-linking bacillus subtilis proteinase crystal.
3. preparation method as claimed in claim 1 or 2 is characterized in that: the temperature in the step () is preferably 44~55 ℃, and stirring velocity is preferably 280~320rpm/min.
4. preparation method as claimed in claim 1 or 2 is characterized in that: the metabisulfite solution concentration described in step (), (two) and (three) is 15%~20%.
5. preparation method as claimed in claim 1 or 2 is characterized in that: the temperature of reaction described in the step (four) is 28~35 ℃, and described stirring velocity is 480~520rpm/min.
6. preparation method as claimed in claim 1 or 2 is characterized in that: described damping fluid is for containing 100mM NaAc and 20mM CaCl 2The aqueous solution, the pH value of solution value is 5.5~5.85.
CN2007100257824A 2007-08-02 2007-08-02 Method for preparing cross-linking bacillus subtilis proteinase crystal Expired - Fee Related CN101139579B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100257824A CN101139579B (en) 2007-08-02 2007-08-02 Method for preparing cross-linking bacillus subtilis proteinase crystal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100257824A CN101139579B (en) 2007-08-02 2007-08-02 Method for preparing cross-linking bacillus subtilis proteinase crystal

Publications (2)

Publication Number Publication Date
CN101139579A CN101139579A (en) 2008-03-12
CN101139579B true CN101139579B (en) 2010-12-08

Family

ID=39191683

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100257824A Expired - Fee Related CN101139579B (en) 2007-08-02 2007-08-02 Method for preparing cross-linking bacillus subtilis proteinase crystal

Country Status (1)

Country Link
CN (1) CN101139579B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101892203A (en) * 2010-07-21 2010-11-24 中国人民解放军第三军医大学 Crystal of thymidylate synthetase (ThyX) of helicobacter pylori and preparation method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976529A (en) * 1990-08-03 1999-11-02 Vertex Pharmaceuticals, Inc. Methods of enzyme therapy by orally administering crosslinked enzyme crystals
CN1408855A (en) * 2001-09-19 2003-04-09 上海化工研究院 method for improving lipase activity stability

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976529A (en) * 1990-08-03 1999-11-02 Vertex Pharmaceuticals, Inc. Methods of enzyme therapy by orally administering crosslinked enzyme crystals
CN1408855A (en) * 2001-09-19 2003-04-09 上海化工研究院 method for improving lipase activity stability

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Paul A. Fitzpatrick et al..X-ray crystal structure of cross-linked subtilisin carlsberg inwater vs. acetonitrile.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATION198 2.1994,198(2),675-681.
Paul A. Fitzpatrick et al..X-ray crystal structure of cross-linked subtilisin carlsberg inwater vs. acetonitrile.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATION198 2.1994,198(2),675-681. *
潘力等.碱性蛋白酶交联酶晶体的制备及稳定性.华南理工大学学报(自然科学版)26 9.1998,26(9),22-26.
潘力等.碱性蛋白酶交联酶晶体的制备及稳定性.华南理工大学学报(自然科学版)26 9.1998,26(9),22-26. *

Also Published As

Publication number Publication date
CN101139579A (en) 2008-03-12

Similar Documents

Publication Publication Date Title
CN101368195A (en) Preparation method for high purity fructo-oligosaccharide
CN104928340A (en) Process for enzymatic synthesis of cefprozil
CN101851151A (en) Method for preparing cyclohexanol by using cyclohexene
CN107312768A (en) A kind of immobilized tannase and its preparation method and application
CN108117168A (en) The purposes of water quality cleansing agent containing biological enzyme
CN102260174A (en) Application of solid acid catalyst to preparation of 2,5-dichloronitrobenzene
CN106834376A (en) A kind of method of Enzyme catalyzed synthesis Xi Gelieting
CN112717911B (en) Solid catalyst for preparing fumaric acid as well as preparation method and application thereof
DD143262A1 (en) PROCESS FOR PREPARING A POLYMER, FOR BINDING NUCLEOPHILENE GROUPS ACTIVATED TRAEGERS
Ohya et al. Recruitment of enzyme activity in albumin by molecular imprinting
CN101139579B (en) Method for preparing cross-linking bacillus subtilis proteinase crystal
CN102453707A (en) Preparation method of immobilized cellulase
CN103864954A (en) Method for extracting peanut meal polysaccharide
CN105732373B (en) The method that one kind prepares the phenylbutyrate of (R) 2 hydroxyl 4
CN102921359A (en) Preparation method of biological capsule for sewage treatment
Tükel et al. Partial purification and immobilization of a new (R)-hydroxynitrile lyase from seeds of Prunus pseudoarmeniaca
CN106008750B (en) A kind of preparation method of low-molecular weight chitoglycan
CN104830940A (en) An enzymatic synthesis process of Amoxicillin
CN104031903B (en) The method of modified polyacrylonitrile resin flexibility immobilized papain
CN109467521B (en) Process for synthesizing 2-cyclamate
CN106755145A (en) A kind of method of the fixed lipase catalyzed synthesizing citric acid ester of utilization nano composite material
CN102703416B (en) Preparation method of immobilized enzyme carrier
CN106978452B (en) Method for synthesizing lauric acid monoester kojic acid by biological method
CN106008321B (en) A kind of preparation method of UV292
CN104846025A (en) Method for preparing (2S, 3R)-2-benzoyl aminomethyl-3-hydroxy methyl butyrate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Yao Yiming

Inventor after: Yuan Fang

Inventor after: Li Rui

Inventor before: Yuan Fang

Inventor before: Li Rui

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: YUAN FANG LI RUI TO: YAO YIMING YUAN FANG LI RUI

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SUZHOU GOODEE PHARMA CO., LTD.

Free format text: FORMER OWNER: ZHANGJIAGANG AOJIE BIOLOGICAL TECHNOLOGY CO., LTD.

Effective date: 20130314

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 215600 SUZHOU, JIANGSU PROVINCE TO: 215123 SUZHOU, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130314

Address after: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 BioBAY Building No. 218 A2

Patentee after: Suzhou Goodee Pharmaceutical Technology Co., Ltd.

Address before: 215600 Overseas Students Pioneer Park, Zhangjiagang Economic Development Zone, Jiangsu

Patentee before: Zhangjiagang Aojie Biological Technology Co., Ltd.

ASS Succession or assignment of patent right

Owner name: SUZHOU RONNSI BIOTECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: SUZHOU GOODEE PHARMA CO., LTD.

Effective date: 20130401

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20130401

Address after: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 BioBAY No. 218 building A2 room 328

Patentee after: Suzhou Ronnsi Biotechnology Co., Ltd.

Address before: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 BioBAY Building No. 218 A2

Patentee before: Suzhou Goodee Pharmaceutical Technology Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101208

Termination date: 20160802

CF01 Termination of patent right due to non-payment of annual fee